BiotechTube

1% Colloidal Oatmeal Balm

Pre-clinicalTerminated
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Eczema

Conditions

Eczema

Trial Timeline

Mar 1, 2015 → Mar 1, 2016

NCT ID
NCT02404493

About 1% Colloidal Oatmeal Balm

1% Colloidal Oatmeal Balm is a pre-clinical stage product being developed by Johnson & Johnson for Eczema. The current trial status is terminated. This product is registered under clinical trial identifier NCT02404493. Target conditions include Eczema.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT02404493Pre-clinicalTerminated

Competing Products

20 competing products in Eczema

See all competitors
ProductCompanyStageHype Score
Colloidal Oatmeal CreamJohnson & JohnsonPhase 3
77
Pimecrolimus cream 1%NovartisApproved
85
AbrocitinibPfizerPhase 3
76
Dupilumab + PlaceboSanofiPhase 2
51
Amlitelimab + PlaceboSanofiPhase 2
51
alitretinoin + PlaceboGSK plcPhase 3
76
DupilumabRegeneron PharmaceuticalsApproved
84
Adventan® (methylprednisolone aceponate 0,1%)BayerPhase 1
30
Ruxolitinib cream + VehicleIncytePhase 3
74
Ruxolitinib cream + VehicleIncytePhase 2
49
Ruxolitinib cream + VehicleIncytePhase 3
74
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%Arcutis BiotherapeuticsPhase 3
72
Roflumilast Cream + Vehicle creamArcutis BiotherapeuticsPhase 3
72
ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 2
47
Roflumilast Cream 0.05% + Vehicle CreamArcutis BiotherapeuticsPhase 3
72
Roflumilast Cream 0.15% + Vehicle CreamArcutis BiotherapeuticsPhase 3
72
ARQ-151 cream 0.15% + ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 1
28
ARQ-252 cream 0.3% + ARQ-252 cream 0.1% + ARQ-252 Vehicle CreamArcutis BiotherapeuticsPhase 1/2
36
LAS41003 + LAS189962 + LAS189961AlmirallPhase 2
47
LAS 41002 + ActiveAlmirallPhase 2
47

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85